Literature DB >> 32094221

Evaluation of primary care 6- to 8-week hip check for diagnosis of developmental dysplasia of the hip: a 15-year observational cohort study.

Ronnie Davies1, Christopher Talbot2, Robin Paton3.   

Abstract

BACKGROUND: The current 6- to 8-week Newborn and Infant Physical Examination (NIPE) clinical assessment is a current standard hip-screening test in the community (England) to detect developmental dysplasia of the hip (DDH). AIM: To assess the value of the primary care 6- to 8-week clinical hip examination for the diagnosis of DDH. DESIGN AND
SETTING: A single-centre 15-year observational cohort study at a district general hospital between 1 January 1996 and 31 December 2010.
METHOD: Those referred by the GP or community practitioner with suspected instability or abnormality of the hip joint (DDH), were clinically and sonographically examined in a specialist hip-screening clinic. Modified Graf Type III and IV, and radiological irreducible hip dislocation were considered to be 'pathological' hips. Screening failures were defined as those who had not been identified by this primary care screening assessment (but had irreducible hip dislocation). Secondary univariate and multivariable analyses were performed to determine which clinical findings are predictive of instability.
RESULTS: Over the study period, there were 70 071 infants who underwent the 6- to 8-week clinical hip assessment. In the specialist hip-screening clinic, six (from the 170 referred) were diagnosed with pathological DDH. The sensitivity, specificity, positive predictive value, and negative predictive value for the 6- to 8-week clinical hip assessment were 16.7%, 99.8%, 3.5%, and 100.0%, respectively. A multivariable model showed a positive Ortolani manoeuvre to be the sole independent predictor of instability at 6 to 8 weeks.
CONCLUSION: This 15-year study highlights the limitations of a hip check at 6 to 8 weeks. These findings support the reassessment of the national guidelines for this aspect of the NIPE DDH screening programme. © British Journal of General Practice 2020.

Entities:  

Keywords:  clinical examination; cohort studies; hip dysplasia; primary healthcare; screening

Mesh:

Year:  2020        PMID: 32094221      PMCID: PMC7041638          DOI: 10.3399/bjgp20X708269

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  27 in total

1.  Neonatal diagnosis, treatment and related factors of congenital dislocation of the hip.

Authors:  T D Artz; W N Lim; P D Wilson; D B Levine; E A Salvati
Journal:  Clin Orthop Relat Res       Date:  1975 Jul-Aug       Impact factor: 4.176

2.  Examining the effectiveness of examination at 6-8 weeks for developmental dysplasia: testing the safety net.

Authors:  Mike Reidy; Caitlin Collins; Jamie G B MacLean; Donald Campbell
Journal:  Arch Dis Child       Date:  2018-12-05       Impact factor: 3.791

3.  Neonatal detection of developmental dysplasia of the hip (DDH)

Authors:  D Jones
Journal:  J Bone Joint Surg Br       Date:  1998-11

4.  An assessment of the value of examination of the hip in the newborn.

Authors:  D Jones
Journal:  J Bone Joint Surg Br       Date:  1977-08

5.  Ultrasound screening for hips at risk in developmental dysplasia. Is it worth it?

Authors:  R W Paton; M S Srinivasan; B Shah; S Hollis
Journal:  J Bone Joint Surg Br       Date:  1999-03

6.  Economic evaluation of ultrasonography in the diagnosis and management of developmental hip dysplasia in the United Kingdom and Ireland.

Authors:  Alastair Gray; Diana Elbourne; Carol Dezateux; Andrew King; Anne Quinn; Frances Gardner
Journal:  J Bone Joint Surg Am       Date:  2005-11       Impact factor: 5.284

7.  Unilateral limitation of abduction of the hip. A valuable clinical sign for DDH?

Authors:  S Jari; R W Paton; M S Srinivasan
Journal:  J Bone Joint Surg Br       Date:  2002-01

8.  Effect of ultrasound screening on the rate of first operative procedures for developmental hip dysplasia in Germany.

Authors:  Rüdiger von Kries; Nicola Ihme; Doris Oberle; Anette Lorani; Renee Stark; Lutz Altenhofen; Fritz Uwe Niethard
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

9.  Is limitation of hip abduction a useful clinical sign in the diagnosis of developmental dysplasia of the hip?

Authors:  Q Choudry; R Goyal; R W Paton
Journal:  Arch Dis Child       Date:  2013-08-14       Impact factor: 3.791

10.  Enhanced detection services for developmental dysplasia of the hip in Scottish children, 1997-2013.

Authors:  David A McAllister; Joanne R Morling; Colin M Fischbacher; Mike Reidy; Alastair Murray; Rachael Wood
Journal:  Arch Dis Child       Date:  2018-02-07       Impact factor: 4.920

View more
  4 in total

1.  Modified Pemberton Pelvic Osteotomy Through Inner Ilium Approach for Treatment of Developmental Dysplasia of the Hip in Children.

Authors:  Yuxi Su; Guoxin Nan
Journal:  Indian J Orthop       Date:  2022-06-27       Impact factor: 1.033

2.  Study protocol for evaluation of aid to diagnosis for developmental dysplasia of the hip in general practice: controlled trial randomised by practice.

Authors:  Andreas Roposch; Kaltuun Warsame; Angel Chater; Judith Green; Rachael Hunter; John Wood; Nick Freemantle; Irwin Nazareth
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

3.  Understanding physician behaviour in the 6-8 weeks hip check in primary care: a qualitative study using the COM-B.

Authors:  Angel Chater; Sarah Milton; Judith Green; Gill Gilworth; Andreas Roposch
Journal:  BMJ Open       Date:  2021-03-19       Impact factor: 2.692

4.  Parents' expectations and experiences of the 6-week baby check: a qualitative study in primary care.

Authors:  Gill Gilworth; Sarah Milton; Angel Chater; Irwin Nazareth; Andreas Roposch; Judith Green
Journal:  BJGP Open       Date:  2020-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.